U.S. markets close in 1 hour 16 minutes
  • S&P 500

    -6.61 (-0.16%)
  • Dow 30

    -82.58 (-0.24%)
  • Nasdaq

    -104.42 (-0.74%)
  • Russell 2000

    -3.54 (-0.15%)
  • Crude Oil

    +1.26 (+1.78%)
  • Gold

    -7.40 (-0.40%)
  • Silver

    -0.28 (-1.01%)

    +0.0007 (+0.06%)
  • 10-Yr Bond

    -0.0020 (-0.13%)

    -0.0025 (-0.17%)

    +0.0260 (+0.02%)

    +1,060.04 (+2.65%)
  • CMC Crypto 200

    +8.54 (+0.85%)
  • FTSE 100

    +25.80 (+0.36%)
  • Nikkei 225

    +279.50 (+0.96%)

Owl Rock Capital (ORCC) Offers Notes Worth $450 Million

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
·3 min read
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

Owl Rock Capital Corporation ORCC recently announced the pricing of its notes, carrying an interest rate of 2.875%. Subject to certain closing conditions, the public offering of worth $450 million notes will mature on Jun 11, 2028.

The net proceeds of the issuance of these notes will be used in clearing debt obligations including the amount under the Revolving Credit Facility due Sep 3, 2025 with respect to $1.295 billion of commitments. The remainder will be used in redeeming all the company’s pending debt that matures on Apr 2, 2024 in relation to its remaining commitments along with the Special Purpose Vehicle (SPV) Asset Facility IV, which matures on Aug 2, 2029.

By capitalizing on the low interest rate environment triggered by the COVID-19 pandemic, the company is attempting to lower its interest burden, thereby aiding margin expansion.

However, its times interest earned stands at 4.4X, way lower than the industry’s average of 37.2X. Its total debt to equity stands at 95.6%, higher than the industry's average of 84.6%. The company’s total liquidity of $2.5 billion is significantly lower than its long-term debt of $5.5 billion.
Nevertheless, it takes measures to enhance its financial flexibility without affecting its liquidity position.

Other factors, such as its strong portfolio, growing top line on the back of interest income, inorganic growth initiatives and capital deployment poise this Zacks Rank #3 (Hold) company well for growth.

Shares of Owl Rock Capital have gained 10.9% in the past year against its industry’s decline of 2.6%.

Zacks Investment Research
Zacks Investment Research

Image Source: Zacks Investment Research

Stocks to Consider

Some better-ranked stocks in the same space are Virtu Financial, Inc. VIRT, Intercorp Financial Services Inc. IFS and XP Inc. XP, all presently holding a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Virtu Financial, Intercorp Financial and XP Inc. managed to deliver a trailing four-quarter surprise of 30%, 257% and 30%, respectively, on average.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Owl Rock Capital Corporation (ORCC) : Free Stock Analysis Report

Virtu Financial, Inc. (VIRT) : Free Stock Analysis Report

XP Inc. (XP) : Free Stock Analysis Report

Intercorp Financial Services Inc. (IFS) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research